Olanzapine
Imran Qureshi, PharmD, BCPP
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Schizophrenia
Manic
or mixed episodes associated with
bipolar I disorder
with or without lithium or valproic acid
Maintenance treatment of
bipolar I disorder
Bipolar I depression (olanzapine/fluoxetine)
Treatment-resistant depression (olanzapine/fluoxetine)
Agitation associated with
schizophrenia
or bipolar I mania (IM)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Management of
delirium
Nausea and vomiting
Anorexia nervosa
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.